These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 11907783)

  • 21. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions.
    Gambhir DS; Mukhopadhyay S
    Indian Heart J; 2000; 52(5):524-32. PubMed ID: 11256774
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycoprotein IIb-IIIa antagonists in percutaneous coronary interventions and acute coronary syndromes.
    Ramanathan A; Kleiman NS
    Indian Heart J; 1998 Oct; 50 Suppl 1():45-56. PubMed ID: 9824907
    [No Abstract]   [Full Text] [Related]  

  • 23. Newer therapeutic concept in antiplatelet aggregation inhibition--GPIIb-IIIa receptor antagonists.
    Malhotra S; Mishra NK; Sinha RS; Gupta B
    J Assoc Physicians India; 2000 Mar; 48(3):329-34. PubMed ID: 11229122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
    Scheller B; Hennen B; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical use of glycoprotein IIb/IIIa inhibitors].
    Simonetti I; Gallopin M; Gensini GF
    Ann Ital Med Int; 1998; 13(3):163-8. PubMed ID: 9859573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glycoprotein IIb/IIIa blockers. Their usefulness in current cardiovascular therapeutics].
    López Cuéllar J
    Arch Inst Cardiol Mex; 1999; 69(3):272-81. PubMed ID: 10529862
    [No Abstract]   [Full Text] [Related]  

  • 27. Post-procedural patient management: prevention and management of bleeding complications.
    Aguirre F
    J Invasive Cardiol; 1994; 6 Suppl A():34A-37A; discussion 54A-56A. PubMed ID: 10155093
    [No Abstract]   [Full Text] [Related]  

  • 28. New antiplatelet agents: platelet GPIIb/IIIa antagonists.
    Coller BS; Anderson K; Weisman HF
    Thromb Haemost; 1995 Jul; 74(1):302-8. PubMed ID: 8578476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet glycoprotein IIb/IIIa inhibitors and thrombocytopenia: possible link between platelet activation, autoimmunity and thrombosis.
    Abrams CS; Cines DB
    Thromb Haemost; 2002 Dec; 88(6):888-9. PubMed ID: 12529733
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombosis, inflammation, and our evolving understanding of vascular biology during interventional therapy.
    Young JJ
    J Invasive Cardiol; 2006 Jan; 18(1):13-5. PubMed ID: 16391377
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Rescue platelet glycoprotein IIb/IIIa inhibitor therapy in thrombosis complicating superficial femoral artery angioplasty.
    Grollman JH; Coil A
    Cardiovasc Intervent Radiol; 2002; 25(1):77-80. PubMed ID: 11907783
    [No Abstract]   [Full Text] [Related]  

  • 32. IIb/IIIa platelet inhibitors in the management of coronary artery disease.
    Talley JD
    J Ark Med Soc; 1996 Oct; 93(5):237-9. PubMed ID: 8908943
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
    Nurden AT; Poujol C; Durrieu-Jais C; Nurden P
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2835-40. PubMed ID: 10591658
    [No Abstract]   [Full Text] [Related]  

  • 34. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
    Mukherjee D; Roffi M
    J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].
    Obradović S; Gligić B; Djordjević D; Jovicić A; Romanović R; Ratković N; Dincić D; Orozović V; Nikolić G
    Vojnosanit Pregl; 2001; 58(1):65-72. PubMed ID: 11419288
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.